Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 31,589 | 36,322 | 40,211 | 31,996 | 14,364 |
| Cost of Goods | 18,636 | 22,249 | 12,985 | 14,701 | 8,245 |
| Gross Profit | 12,953 | 14,073 | 27,226 | 17,295 | 6,119 |
| Operating Expenses | 4,576 | 6,108 | 6,511 | 6,843 | 5,266 |
| Operating Income | 9,013 | 8,214 | 21,700 | 11,154 | 1,098 |
| Interest Expense | 80 | 83 | 159 | 189 | 78 |
| Other Income | 11,901 | 7,559 | -22,105 | 8,307 | -11,673 |
| Pre-tax Income | 20,834 | 15,690 | -564 | 19,272 | -10,653 |
| Income Tax | 2,240 | 1,988 | 5,321 | 2,274 | 239 |
| Net Income Continuous | 18,594 | 13,702 | -5,885 | 16,998 | -10,892 |
| Net Income | $18,594 | $13,702 | $-5,885 | $16,998 | $-10,892 |
| EPS Basic Total Ops | 0.02 | 0.01 | -0.01 | 0.02 | -0.01 |
| EPS Basic Continuous Ops | 0.02 | 0.01 | -0.01 | 0.02 | -0.01 |
| EPS Diluted Total Ops | 0.01 | 0.01 | -0.01 | 0.02 | -0.01 |
| EPS Diluted Continuous Ops | 0.02 | 0.01 | -0.01 | 0.02 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.01 | 0.00 | -0.01 | 0.01 | -0.01 |
| EBITDA(a) | $9,524 | $8,728 | $22,212 | $11,678 | $1,591 |